Gustavo A. Rosario Benitez

Array ( [id] => 6031056 [patent_doc_number] => 20110081361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'ANTIBODIES THAT BIND INTERLEUKIN-4 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/965564 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40516 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081361.pdf [firstpage_image] =>[orig_patent_app_number] => 12965564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495466 [patent_doc_number] => 20120294874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/510690 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22938 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8196821 [patent_doc_number] => 20120121503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Inhibition Of CD69 For Treatment Of Inflammatory Conditions' [patent_app_type] => utility [patent_app_number] => 12/945153 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14162 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121503.pdf [firstpage_image] =>[orig_patent_app_number] => 12945153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030823 [patent_doc_number] => 20110081292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Methods Of Treating Viral Hepatitis' [patent_app_type] => utility [patent_app_number] => 12/944432 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 49225 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081292.pdf [firstpage_image] =>[orig_patent_app_number] => 12944432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8188345 [patent_doc_number] => 08182816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Methods of treating cancer' [patent_app_type] => utility [patent_app_number] => 12/944338 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 54 [patent_no_of_words] => 49221 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182816.pdf [firstpage_image] =>[orig_patent_app_number] => 12944338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790504 [patent_doc_number] => 20120052060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Human Antibody Molecules For IL-13' [patent_app_type] => utility [patent_app_number] => 12/941677 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35703 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052060.pdf [firstpage_image] =>[orig_patent_app_number] => 12941677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149249 [patent_doc_number] => 09181527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'T cell receptor-deficient T cell compositions' [patent_app_type] => utility [patent_app_number] => 13/502978 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14793 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149249 [patent_doc_number] => 09181527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'T cell receptor-deficient T cell compositions' [patent_app_type] => utility [patent_app_number] => 13/502978 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14793 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149249 [patent_doc_number] => 09181527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'T cell receptor-deficient T cell compositions' [patent_app_type] => utility [patent_app_number] => 13/502978 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14793 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149249 [patent_doc_number] => 09181527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'T cell receptor-deficient T cell compositions' [patent_app_type] => utility [patent_app_number] => 13/502978 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14793 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464659 [patent_doc_number] => 20120269826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'ANTI-CD3 ANTIBODY DOSING IN AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/502618 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 55768 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903639 [patent_doc_number] => 20130171142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'METHODS OF USING ANTI-CD3 ANTIBODIES TO PREVENT WEIGHT GAIN' [patent_app_type] => utility [patent_app_number] => 13/502625 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27824 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311261 [patent_doc_number] => 08652477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation' [patent_app_type] => utility [patent_app_number] => 12/905972 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 70 [patent_no_of_words] => 79528 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12905972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055077 [patent_doc_number] => 20110111437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Biomarkers For Prognosis of Pulmonary Diseases' [patent_app_type] => utility [patent_app_number] => 12/901226 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 27004 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111437.pdf [firstpage_image] =>[orig_patent_app_number] => 12901226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125504 [patent_doc_number] => 20110086051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'SYSTEM AND METHOD FOR MONITORING AND OPTIMIZING IMMUNE STATUS IN TRANSPLANT RECIPIENTS' [patent_app_type] => utility [patent_app_number] => 12/900450 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4376 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086051.pdf [firstpage_image] =>[orig_patent_app_number] => 12900450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9761727 [patent_doc_number] => 08846047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Monoclonal antibodies against HMGB1' [patent_app_type] => utility [patent_app_number] => 12/897453 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 54 [patent_no_of_words] => 24825 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12897453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148700 [patent_doc_number] => 20110020295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'PRE-TRANSPLANT ACCOMMODATED ORGANS RESISTANT TO ANTI-DONOR IMMUNITY' [patent_app_type] => utility [patent_app_number] => 12/897297 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11471 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020295.pdf [firstpage_image] =>[orig_patent_app_number] => 12897297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148742 [patent_doc_number] => 20110020337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/896754 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 72948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020337.pdf [firstpage_image] =>[orig_patent_app_number] => 12896754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9468418 [patent_doc_number] => 08722048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'T-cell receptor capable of recognising an antigen from cytomegalovirus' [patent_app_type] => utility [patent_app_number] => 13/498564 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9128 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863451 [patent_doc_number] => 08889141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'T-cell receptor' [patent_app_type] => utility [patent_app_number] => 13/498561 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7639 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498561 [rel_patent_id] =>[rel_patent_doc_number] =>)